30194-9/asset/e2a34f3b-6f8a-425f-9e34-2cf394cbb616/main.assets/gr4_lrg.jpg)
oral semaglutide efficacy and safety of with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial Lesson: Oral Semaglutide: A New
Description
Predictable costs, real outcomes, and a program people actually stay with
Trial registration ClinicalTrials.gov NCT05071950
Just results
Scientists don't fully understand the mechanism yet, but people taking GLP-1 drugs tend to eat less ultra-processed food, more fibre, fruit and vegetables, smaller portions, and fewer snacks
Taking weight loss medicines can avert the long process of dealing with the FAA in cases of heart disease or diabetes
#LetsTalkGERD
